Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05098132 |
|---|---|
| Brief Title: | Phase 1a/1b Study of STK-012 Monotherapy and in Combination With Pembrolizumab in Patients With Solid Tumors |
| First Submitted : | October 6, 2021 |
| First Submitted that Met QC Criteria : | October 20, 2021 |
| First Posted : | October 28, 2021 |
| Last Update Submitted that Met QC Criteria : | January 11, 2024 |
| Last Update Posted : | January 12, 2024 |